WASHINGTON, Nov. 27, 2012 /PRNewswire-USNewswire/ -- The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) today announced that it has selected Pisgah Laboratories' abuse-deterrent technology platform as one of its Top 5 Technologies To Reduce Prescription Drug Abuse.
Pisgah Laboratories' lead abuse-deterrent technology product candidate Hydrocodone/APAP, is intended to provide relief to patients in need of treatment, yet lessen the potential for drug abuse.
According to Bill Bristol, the company's founder and CEO, "Employing organic chemistry, Pisgah's technology addresses prescription drug abuse at the core of the demand, a product's active ingredient. We're grateful for CLAAD's recognition of our innovation."
The Top 5 Technologies competition aims to increase public awareness of the U.S. prescription drug abuse epidemic, and to support private-sector efforts to address the problem.
Michael Barnes, spokesman for CLAAD, stated, "We support Pisgah's efforts to develop novel medications to advance patient care and simultaneously inhibit abuse."
San Diego-based Millennium Laboratories co-sponsored the Top 5 Technologies contest. Millennium provides medication monitoring, drug detection and pharmacogenetic testing services.
"We are proud to recognize Pisgah Laboratories for joining Millennium and CLAAD in our efforts to advance patient care and reduce prescription drug abuse," said Howard Appel, President of Millennium Laboratories.
About the Center for Lawful Access and Abuse Deterrence
The not-for-profit Center for Lawful Access and Abuse Deterrence (CLAAD) is a national coalition of health care providers, law enforcement, community organizations, and businesses working together to reduce prescription drug abuse while optimizing patient care. CLAAD's National Prescription Drug Abuse Prevention S
Copyright©2012 PR Newswire.
All rights reserved